TR199801609A2 - Antipsoriyatik etkili t�rnak cilas�. - Google Patents

Antipsoriyatik etkili t�rnak cilas�.

Info

Publication number
TR199801609A2
TR199801609A2 TR1998/01609A TR9801609A TR199801609A2 TR 199801609 A2 TR199801609 A2 TR 199801609A2 TR 1998/01609 A TR1998/01609 A TR 1998/01609A TR 9801609 A TR9801609 A TR 9801609A TR 199801609 A2 TR199801609 A2 TR 199801609A2
Authority
TR
Turkey
Prior art keywords
nail polish
antipsoriatic
antipsoriatic nail
nail
unresolvable
Prior art date
Application number
TR1998/01609A
Other languages
English (en)
Turkish (tr)
Other versions
TR199801609A3 (tr
Inventor
Bohn Manfred
Theodor Kraemer Karl
Original Assignee
Hoechst Marion Roussel Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Deutschland Gmbh filed Critical Hoechst Marion Roussel Deutschland Gmbh
Publication of TR199801609A3 publication Critical patent/TR199801609A3/tr
Publication of TR199801609A2 publication Critical patent/TR199801609A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR1998/01609A 1997-08-21 1998-08-19 Antipsoriyatik etkili t�rnak cilas�. TR199801609A2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19736112 1997-08-21

Publications (2)

Publication Number Publication Date
TR199801609A3 TR199801609A3 (tr) 1999-03-22
TR199801609A2 true TR199801609A2 (xx) 1999-03-22

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01609A TR199801609A2 (xx) 1997-08-21 1998-08-19 Antipsoriyatik etkili t�rnak cilas�.

Country Status (35)

Country Link
US (3) US6352686B2 (cg-RX-API-DMAC7.html)
EP (1) EP0913154B1 (cg-RX-API-DMAC7.html)
JP (1) JPH11130679A (cg-RX-API-DMAC7.html)
KR (1) KR100610517B1 (cg-RX-API-DMAC7.html)
CN (1) CN1155386C (cg-RX-API-DMAC7.html)
AR (1) AR015933A1 (cg-RX-API-DMAC7.html)
AT (1) ATE227993T1 (cg-RX-API-DMAC7.html)
AU (1) AU740615B2 (cg-RX-API-DMAC7.html)
BG (1) BG63270B1 (cg-RX-API-DMAC7.html)
BR (1) BR9803756A (cg-RX-API-DMAC7.html)
CA (1) CA2245637C (cg-RX-API-DMAC7.html)
CO (1) CO4960649A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ292344B6 (cg-RX-API-DMAC7.html)
DE (1) DE59806343D1 (cg-RX-API-DMAC7.html)
DK (1) DK0913154T3 (cg-RX-API-DMAC7.html)
ES (1) ES2186952T3 (cg-RX-API-DMAC7.html)
HR (1) HRP980458B1 (cg-RX-API-DMAC7.html)
HU (1) HUP9801898A3 (cg-RX-API-DMAC7.html)
ID (1) ID20731A (cg-RX-API-DMAC7.html)
IL (1) IL125854A (cg-RX-API-DMAC7.html)
MY (1) MY128558A (cg-RX-API-DMAC7.html)
NO (1) NO319391B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ331443A (cg-RX-API-DMAC7.html)
PL (1) PL192342B1 (cg-RX-API-DMAC7.html)
PT (1) PT913154E (cg-RX-API-DMAC7.html)
RO (1) RO118174B1 (cg-RX-API-DMAC7.html)
RU (1) RU2210354C2 (cg-RX-API-DMAC7.html)
SG (1) SG68072A1 (cg-RX-API-DMAC7.html)
SI (1) SI0913154T1 (cg-RX-API-DMAC7.html)
SK (1) SK284218B6 (cg-RX-API-DMAC7.html)
TR (1) TR199801609A2 (cg-RX-API-DMAC7.html)
TW (1) TW590776B (cg-RX-API-DMAC7.html)
UA (1) UA51693C2 (cg-RX-API-DMAC7.html)
YU (1) YU49492B (cg-RX-API-DMAC7.html)
ZA (1) ZA987531B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
KR20030072592A (ko) * 2001-01-09 2003-09-15 이스라엘 드보레츠키 치료용 필름 형성 조성물 및 치료 시스템
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
RU2361594C2 (ru) * 2002-12-17 2009-07-20 Галдерма Са Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
EP1888026A4 (en) 2005-05-27 2012-07-04 Taro Pharmaceuticals North America Inc STABLE LIQUID FORMULATION WITH DESOXIMETASON AND ISOPROPYLMYRISTATE WITH REDUCED OXIDIZED CONTAMINATION DURING LONG-TERM STORAGE
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
ES2742525T3 (es) * 2009-10-01 2020-02-14 Adare Pharmaceuticals Us L P Composiciones de corticosteroides administradas oralmente
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
CN119604309A (zh) * 2022-07-28 2025-03-11 花王株式会社 外用剂组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
DE3687458T2 (de) * 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
WO1995003838A1 (en) * 1993-07-28 1995-02-09 Pfizer Inc. Psoriasis treatment
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
WO1997034644A1 (de) * 1996-03-16 1997-09-25 Hoechst Aktiengesellschaft Topische formulierungen zur behandlung von nagel-psoriasis
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Also Published As

Publication number Publication date
AU8085698A (en) 1999-03-04
SG68072A1 (en) 1999-10-19
TW590776B (en) 2004-06-11
AU740615B2 (en) 2001-11-08
NZ331443A (en) 1999-01-28
HRP980458A2 (en) 1999-06-30
JPH11130679A (ja) 1999-05-18
HK1018214A1 (en) 1999-12-17
CN1155386C (zh) 2004-06-30
PT913154E (pt) 2003-04-30
ES2186952T3 (es) 2003-05-16
BR9803756A (pt) 2000-03-28
SK114398A3 (en) 1999-03-12
CZ263298A3 (cs) 1999-03-17
TR199801609A3 (tr) 1999-03-22
HUP9801898A3 (en) 2000-01-28
CO4960649A1 (es) 2000-09-25
BG63270B1 (bg) 2001-08-31
UA51693C2 (uk) 2002-12-16
AR015933A1 (es) 2001-05-30
EP0913154B1 (de) 2002-11-20
KR100610517B1 (ko) 2007-04-25
SK284218B6 (en) 2004-11-03
CA2245637A1 (en) 1999-02-21
US20020071815A1 (en) 2002-06-13
US6352686B2 (en) 2002-03-05
RU2210354C2 (ru) 2003-08-20
BG102696A (en) 1999-04-30
NO319391B1 (no) 2005-08-08
US20010006625A1 (en) 2001-07-05
HUP9801898A1 (hu) 1999-04-28
YU49492B (sh) 2006-08-17
ID20731A (id) 1999-02-25
IL125854A0 (en) 1999-04-11
EP0913154A1 (de) 1999-05-06
PL192342B1 (pl) 2006-10-31
CZ292344B6 (cs) 2003-09-17
RO118174B1 (ro) 2003-03-28
IL125854A (en) 2004-02-19
YU34998A (sh) 2002-11-15
DE59806343D1 (de) 2003-01-02
SI0913154T1 (en) 2003-04-30
MY128558A (en) 2007-02-28
ATE227993T1 (de) 2002-12-15
HRP980458B1 (en) 2002-12-31
DK0913154T3 (da) 2003-03-03
US20040071645A1 (en) 2004-04-15
PL328122A1 (en) 1999-03-01
HU9801898D0 (en) 1998-10-28
CN1209318A (zh) 1999-03-03
NO983818L (no) 1999-02-22
ZA987531B (en) 1999-02-22
CA2245637C (en) 2008-07-15
NO983818D0 (no) 1998-08-20
KR19990023719A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
TR199801609A2 (xx) Antipsoriyatik etkili t�rnak cilas�.
BR9306683A (pt) Adesivo proteináceo curado com aldeído
ATE188374T1 (de) Sonnenschutzmittel
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
BR9812853A (pt) Sistema catalizador, processo para preparar uma poliolefina, e, uso de um sistema catalisador
DK0711140T3 (da) Antimykotisk opløsning til negle
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
ATE237352T1 (de) Helfervirus-freie herstellung von aav
TR199801475T2 (xx) T�rnak uzamas�n� h�zland�ran bile�imler.
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
DE69814135D1 (de) 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel
BR9803694A (pt) ácidos 6- e 7-aminotetraidroisoquinolinacarboxìlico substituìdos.
ES2181763T3 (es) Formulaciones a base de fenbendazol.
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
AU580890B2 (en) P-acylaminobenzamides
DE69428909D1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
FI870058A0 (fi) Foerfarande foer framstaellning av baernstenssyramon/(2-dimetylamino)etylester/succinat.
CA2088588A1 (en) Treatment of hair loss and dermatological problems
ES2141457T3 (es) Procedimiento de ayuda a la interaccion entre una primera y una segunda unidades.
ECSP951483A (es) Heteroaril--oxazolidinonas de 5 eslabones que contienen nitrogeno
FR2604172B1 (fr) La 2-methyldecanaloxime et ses utilisations en tant que matiere odorante
IT1255639B (it) Uso dell'oxatomide come agente antitosse